4//SEC Filing
Mahatme Sandesh 4
Accession 0001209191-20-035519
CIK 0001636282other
Filed
Jun 9, 8:00 PM ET
Accepted
Jun 10, 4:28 PM ET
Size
5.4 KB
Accession
0001209191-20-035519
Insider Transaction Report
Form 4
Mahatme Sandesh
Director
Transactions
- Award
Director Stock Option (right to buy)
2020-06-08+28,100→ 28,100 totalExercise: $8.89Exp: 2030-06-07→ Common Stock (28,100 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable in 12 equal monthly installments beginning on July 8, 2020 until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.
Documents
Issuer
Aeglea BioTherapeutics, Inc.
CIK 0001636282
Entity typeother
Related Parties
1- filerCIK 0001511034
Filing Metadata
- Form type
- 4
- Filed
- Jun 9, 8:00 PM ET
- Accepted
- Jun 10, 4:28 PM ET
- Size
- 5.4 KB